Lung Cancer
News
Adjuvant erlotinib showed no benefit in NSCLC patients
Key clinical point: Adjuvant erlotinib demonstrated no DFS benefit in patients with non–small-cell lung cancer (NSCLC) whose tumors expressed...
Feature
Genomic oncology: moving beyond the tip of the iceberg
Original Report
Treatment outcomes in stage IIIA non–small-cell lung cancer in a community cancer center
Reviews
Lung cancer in HIV-infected patients and the role of targeted therapy
News
Vemurafenib looks promising for several nonmelanoma malignancies
Key clinical point: Vemurafenib shows promising activity against several nonmelanoma cancers with BRAF V600 mutations, including non–small cell...
News
Immune-related patterns of response present challenges
News
Solid histology predicts poor survival in resected lung adenocarcinoma
Key clinical point: Predominantly solid tumor histology predicted earlier recurrence and poorer postrecurrence survival (PRS) in surgically...
News
Limited resection inferior for elderly with early NSCLC
Key clinical point: Limited resection is inferior to lobectomy for older patients with early-stage invasive NSCLC. Major finding: Limited...